Infections of the Breast


Breast infection is uncommon in the United States, yet it still occurs, even in neonates. It usually affects women between 18 and 50 years of age. Breast infections in adults can be divided into two basic types: lactational and nonlactational infections. The breast infection can extend to the skin overlying the breast, or it may be secondary to a primary skin infection such as a ruptured keratinous cyst or to an underlying condition such as hidradenitis suppurativa. Whatever the cause and the circumstances, breast infections should be treated early and aggressively. First, appropriate antibiotics should be given early to reduce formation of abscesses. Second, hospital referral is indicated if the infection does not settle rapidly with antibiotics. Third, if an abscess is suspected, it should be confirmed by aspiration before it is drained surgically. Finally, breast cancer should be excluded in patients with an inflammatory lesion that is solid on aspiration or that does not settle despite apparently adequate treatment.

Neonatal breast infection is most common in the first few weeks of life when the breast bud is enlarged. Staphylococcus aureus is the usual organism, but occasionally Escherichia coli is the cause. If an abscess develops, the incision to drain the pus should be placed as peripherally as possible to avoid damaging the breast bud because damage to the breast bud will impair normal breast growth and development.

Neonatal breast infections are not the only concern for the neonate. Infectious disease is a leading cause of morbidity and hospitalization for infants and children. During infancy, breastfeeding protects against infectious diseases, particularly respiratory infections, gastrointestinal (GI) infections, and otitis media. Little is known, however, about the longer-term impact of breastfeeding on infectious disease in children. Tarrant and coworkers investigated the relationship between infant feeding and childhood hospitalizations from respiratory and GI infections in a population-based birth cohort of 8,327 children born in 1997 and followed for 8 years. These investigators found that giving breast milk and no formula for at least 3 months substantially reduced hospital admissions for many infectious diseases in the first 6 months of life, when children are most vulnerable. Beyond 6 months of age, there was no association between breastfeeding status at 3 months and hospitalization for infectious disease.

Despite this positive effect of breastfeeding, some worry that breastfeeding itself may lead to systemic neonatal infections. Indeed, mother-to-child transmission of hepatitis B virus (HBV) is among the most important causes of chronic HBV infection and is the most common mode of transmission worldwide. The presence of hepatitis B surface antigen (HBsAg), hepatitis B early antigen (HBeAg), and HBV DNA in breast milk has been confirmed, but several studies have reported that breastfeeding carries no additional risk that might lead to vertical transmission. Beyond some limitations, the surveys thus far have not demonstrated any differences in HBV transmission rate regarding feeding practices in early childhood.

Furthermore, breastfeeding remains a common practice in parts of the world where the burden of human immunodeficiency virus (HIV) is highest and the fewest alternative feeding options exist. Thus HIV-positive mothers are faced with the dilemma of whether to breastfeed their infants. This is in keeping with regional cultural norms, but in doing so, the mother risks transmitting the virus through breast milk. Furthermore, subclinical mastitis is common in HIV-infected women and is a contributing risk factor for mother-to-child transmission of HIV. The alternative is to pursue formula feeding, which reduces transmission of HIV but comes with its own set of risks, including a higher rate of infant mortality from diarrheal illnesses. Treatment of mothers and/or their infants with antiretroviral (ART) drugs is a strategy that has been used for several decades to reduce HIV transmission through pregnancy and delivery, but the effect of these agents when taken during breastfeeding is incompletely studied. Exclusive breastfeeding is much safer than mixed feeding (i.e., the supplementation of breastfeeding with other foods) and should be encouraged even in settings where ART for either the mother or the infant is not readily available. The research published regarding maternal treatment with highly active antiretroviral therapy (HAART) during pregnancy and the breastfeeding period has all been nonrandomized with relatively little statistical power but suggests maternal HAART can drastically reduce the risk of transmission of HIV. Infant prophylaxis has been intensively studied in several trials and has been shown to be as effective as maternal treatment with antiretrovirals, reducing the transmission rate after 6 weeks to as low as 1.2%. There is hope that perinatal HIV transmission may be greatly reduced in breastfeeding populations worldwide through a combination of behavioral interventions that encourage exclusive breastfeeding and pharmacological interventions with ART for mothers and/or their infants.

Lactational Breast Infection

Clinical Presentation

Abscess of the breast usually results from rupture of mammary ducts often, but not always, with pregnancy and lactation. These abscesses present as swollen, often erythematous, and painful breast masses, which may simulate carcinoma. Lactation-related breast infection is most frequently seen within the first 6 weeks of breastfeeding, although some women have it with weaning, and the lactating infection presents with pain, swelling, and tenderness. There is usually a history of a cracked nipple or skin abrasion. S. aureus is the most common organism responsible, but Staphylococcus epidermidis and streptococci are occasionally cultured.

Key Clinical Features

Lactational Breast Infections

  • 1.

    Cause likely due to rupture of mammary ducts.

  • 2.

    Present as swollen, erythematous, and painful masses.

  • 3.

    May simulate carcinoma.

  • 4.

    Most occur within the first 6 weeks of breastfeeding.

  • 5.

    Often there is a history of a cracked nipple or skin abrasion.

  • 6.

    S. aureus is most common; S. epidermidis and streptococci are less common.

Gross Pathology

The typical abscess causes an edematous pink-red mass, which is cavitated centrally and filled with yellow viscous fluid (pus).

Microscopic Pathology

Breast tissue is displaced by chronic-active inflammation with numerous neutrophils, mixed with scattered plasma cells and histiocytes ( Fig. 3.1 ). Special stains may demonstrate causative organisms.

Fig. 3.1, Breast abscess . ( A ) Central involvement of ducts, packed with neutrophils. ( B ) Areas of chronic inflammation centered on smaller ducts. ( C ) Breast abscess marked by plasma cells, neutrophils, and histiocytes. ( D ) Gram stain showing bacterial organisms.

Treatment and Prognosis

All abscesses in the breast can be managed by repeated aspiration or incision and drainage. Few breast abscesses require drainage with the patient under general anesthesia, except those in children, and placement of a drain after incision and drainage is unnecessary. Better maternal and infant hygiene and early treatment with antibiotics have considerably reduced the incidence of abscess formation during lactation. Dener and Inan assessed contributing factors in developing puerperal breast abscess and evaluated the treatment options. During the 4-year study period, 128 nursing women with breast infection were followed. Of these, 102 (80%) had mastitis, and 26 (20%) had breast abscess. All patients with mastitis were treated with antibiotics, and none had an abscess. Ten abscesses were aspirated, and 16 abscesses were treated by incision and drainage. Healing times were similar. There was no significant difference between the mastitis and the abscess groups regarding age, parity, localization of breast infection, cracked nipples, positive milk cultures, or mean lactation time. Duration of symptoms and healing were longer in cases of abscess. Multivariate analyses showed that duration of symptoms was the only independent variable for abscess development. Recurrent mastitis developed in 13 (10.2%) patients within a median of 24 weeks of follow-up. The authors found that delayed treatment of mastitis can lead to abscess formation and that it can be prevented by early antibiotic therapy. Ultrasonography was helpful for detecting abscess formation, and in selected cases, the abscess can be drained with needle aspiration with excellent cosmesis.

Drainage of milk from the affected segment should be encouraged and is best achieved by continuing breastfeeding. Tetracycline, ciprofloxacin, and chloramphenicol should not be used to treat lactating breast infection because they may enter breast milk and can harm the baby. If the inflammation or an associated mass lesion still persists, further investigations are required to exclude an underlying carcinoma. An established abscess should be treated by either recurrent aspiration or incision and drainage. Many women wish to continue to breastfeed, and they should be encouraged to do so.

Differential Diagnosis

Putative abscesses that have solid areas or do not respond to therapy should be considered potential carcinomas, and tissue biopsy should be taken to rule out this possibility. Finally, not all that appear to be abscesses in these patient groups are abscesses. Galactoceles, noninfected milk-filled cysts, present as tender masses; aspiration is both diagnostic and curative. Benign fibroadenomas occasionally enlarge significantly or infarct during pregnancy. A physiological nipple discharge is common during pregnancy and may be bloody. Rare cases of massive breast hypertrophy during pregnancy have been reported. Death from breast cancer during pregnancy is related to delay in diagnosis: compared stage for stage with nonpregnant controls, the prognosis is similar. As a general rule, the cancer should be treated surgically, and the pregnancy may be allowed to progress.

One of the differential diagnoses is primary squamous cell carcinoma (SCC) of the breast, a rare neoplasm in this age group, with fewer than 100 cases reported in the English-language literature. However, primary breast SCC seems to have a propensity to mimic breast abscess, and these patients can be misdiagnosed and initially treated for breast abscess. There may be skin erythema associated with an underlying mass, and an infectious cause is often considered in these cases. These tumors unfortunately tend to be large (in the 4- to 5-cm range) and diagnosed at an advanced stage. For this reason, breast biopsy should be considered in cases of breast abscess, especially if there are any atypical features. Treatment of primary SCC of the breast is like that of more common types of breast cancer (i.e., breast conservation is possible and sentinel lymph node biopsy is recommended). Because metastasis to the breast from other primary tumor sites (lung, cervix, skin, and esophagus) has been reported, patients with pure SCC should undergo evaluation to exclude this possibility.

Key Pathological Features

Lactational Breast Infections

  • 1.

    Cause edematous pink-red, variably firm masses.

  • 2.

    May be cavitated centrally and filled with yellow viscous fluid (pus).

  • 3.

    May include chronic-active inflammation with neutrophils, mixed with plasma cells.

  • 4.

    Special stains may demonstrate causative organisms.

Nonlactational Breast Infection

Clinical Presentation

Nonlactational infections can be separated into those occurring centrally in the periareolar region and those affecting the peripheral breast tissue. Periareolar infection is most commonly seen in women in their early 30 s.

Histologically, there is acute inflammation around nondilated subareolar breast ducts; a condition termed by some as periductal mastitis. This condition has been confused with and called duct ectasia, but duct ectasia is a separate condition affecting an older age group characterized by subareolar duct dilatation with less pronounced and mostly chronic (lymphocytic and histiocytic) periductal inflammation. Current evidence suggests that smoking is an important factor in the cause of periductal mastitis but not in duct ectasia. About 90% of women who get periductal mastitis or its complications smoke cigarettes compared with 38% of the same age group in the general population. Rare cases of subareolar breast abscess have been reported in male patients.

The importance of smoking was recently underscored in a study by Gollapalli and colleagues. This group investigated risk factors that predispose to the development of primary breast abscesses and subsequent recurrence. It was a case-control study of patients with a primary or recurrent breast abscess, with recurrence defined by the need for repeated drainage within 6 months. Sixty-eight patients with a primary breast abscess were identified. Univariate analysis indicated that smoking, obesity, diabetes mellitus, and nipple piercing were significant risk factors for development of primary breast abscess. Multivariate logistic regression analysis confirmed smoking as a significant risk factor for the development of primary breast abscess, and in the subtype of subareolar breast abscess, nipple piercing was identified as a risk factor in addition to smoking. Recurrent breast abscess occurred in 36 (53%) patients.

A second study points toward not only smoking but also other contributing factors. Bharat and associates investigated the patients’ and the microbiological risk factors that predispose to the development of primary breast abscesses and subsequent recurrence. Recurrent breast abscess was defined by the need for repeated drainage within 6 months. Patient characteristics were compared with the general population and between groups. A total of 89 patients with a primary breast abscess were identified; 12 (14%) were lactational and 77 (86%) were nonlactational. None of the lactational abscesses recurred, whereas 43 (57%) of the nonlactational abscesses did so. Compared with the general population, patients with a primary breast abscess were predominantly Black (64% versus 12%), had higher rates of obesity (body mass index >30: 43% versus 22%), and were tobacco smokers (45% versus 23%). The only factor significantly associated with recurrence in the multivariate logistic regression analysis was tobacco smoking. Compared with patients who did not have a recurrence, patients with recurrent breast abscesses had a higher incidence of mixed bacteria (20.5% versus 8.9%), anaerobes (4.5% versus 0%), and Proteus infection (9.1% versus 4.4%) but a lower incidence of Staphylococcus infection (4.6% versus 24.4%). Risk factors for development of a primary breast abscess include Black race, obesity, and tobacco smoking. Patients with recurrent breast abscesses are more likely to be smokers and have mixed bacterial and anaerobic infections. Broader antibiotic coverage should be considered for the higher-risk groups. Substances in cigarette smoke may either directly or indirectly damage the wall of the subareolar breast ducts. The damaged tissues then become infected by either aerobic or anaerobic organisms. Initial presentation may be with periareolar inflammation (with or without an associated mass) or with an established abscess. Associated features include central breast pain, nipple retraction at the site of the diseased duct, and nipple discharge.

Key Clinical Features

Nonlactational Breast Infection

  • 1.

    Causes an edematous pink-red lump.

  • 2.

    Can be separated into central periareolar and peripheral types.

  • 3.

    Periareolar infection is common in women in their early 30 s.

  • 4.

    Smoking and nipple piercing are significant risk factors for periareolar abscesses.

  • 5.

    May be complicated by mammary duct fistula between skin and abscess. Peripheral abscesses are often associated with diabetes, rheumatoid arthritis, steroid treatment, granulomatous lobular mastitis, and trauma.

Gross Pathology

The typical abscess causes an edematous pink-red mass, which is cavitated centrally and filled with yellow viscous fluid (pus). A mammary duct fistula is a communication between the skin, usually in the periareolar region and a major subareolar breast duct. A fistula can develop after incision and drainage of a nonlactational abscess, it can follow spontaneous discharge of a periareolar inflammatory mass, or it can result from biopsy of a periductal inflammatory mass. Treatment is by excision of the fistula and diseased duct or ducts under antibiotic cover. Recurrence is common after surgery, and the lowest rates of recurrence and best cosmetic results have been achieved in specialist breast units. Surgery performed through a circumareolar incision gives excellent cosmetic results.

Microscopic Pathology

Breast tissue is displaced by chronic-active inflammation with numerous neutrophils, mixed with scattered plasma cells and histiocytes. Special stains may demonstrate causative organisms.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here